EGFR and gastric cancer: It is also reported that the growth of gastric cancer cells in mice is significantly inhibited by treatment with 25 μg/mL of taraxasterol for 16 days, and a mechanism study demonstrates that taraxasterol inhibited the growth of gastric cancer cells in mice by inhibition of EGFR/AKT1 signaling [40].